Wednesday, Feb 24, 1988

Genentech Names Three Vice Presidents

South San Francisco, Calif. -- February 24, 1988 --

Genentech, Inc. today announced the appointment of David Botstein, Ph.D. as vice president - science and Allen F. Woodhour, Ph.D. as vice president - regulatory affairs, and the promotion of Gary A. Lyons to vice president - sales.

Botstein, 46, will contribute to maintaining the vitality and creativity of Genentech's scientists as the company grows.

He joins Genentech from the Massachusetts Institute of Technology (M.I.T.) where he held the position of Earle A. Griswold Professor of Genetics. During his 20-year association with M.I.T., he progressed from instructor to professor of genetics in the Department of Biology in which he conducted research in genetic approaches to biological problems, and in the use of linkage methods and DNA markers in human genetics.

Botstein's career has been marked by numerous distinctions and awards including the election to the National Academy of Sciences and the Eli Lilly Award in Microbioloy and Immunology. He serves on the boards of various scientific journals and advisory committees including the Genetics Society of America. He has published more than 100 scientific publications, and is the author of "A Manuai for Genetic Engineering - Advanced Bacterial Genetics," the first comprehensive laboratory textbook including recombinant DNA methods.

Botstein earned an A.B. degree cum laude in biochemical sciences from Harvard College and a Ph.D. in human genetics from the University of Michigan.

Woodhour, 57, will be responsible for managing Genentech's Regulatory Affairs department.

He joins Genentech following a 27-year association with Merck Sharp & Dohme Research Laboratories (MSDRL) where he was senior director, regulatory affairs. In this position he directed all of the company's regulatory efforts concerning biological and opthalmic products. Earlier at MSDRL, he conducted and managed research specializing in virus and cell biology, and directed regulatory matters concerning experimental products.

Woodhour holds 13 patents in biological research developments and has published more than 40 research papers. He has been honored with membership on several ad hoc committees to the World Health Organization and the European Economic Community.

He earned a B.A. degree from St. Vincent College in Latrobe, Pennsylvania and an M.S. and Ph.D. degree from Catholic University in Washington, D.C.

Lyons, 36, has served as director of sales at Genentech since 1983. During that time, he managed the recruitment, development and expansion of the company's sales force to its present size of 175 professionals.

Lyons began his career with American Critical Care, a division of American Hospital Supply Corporation. During his nine-year association with that company, he held key sales management positions that resulted in his promotion to director of sales for domestic operations.

Genentech is a leading biotechnology company focusing on the development, manufacture and marketing of pharmaceuticals produced by recombinant DNA technology.

# # #